Characteristics Associated with Functional Changes During Systemic Cancer Treatments: A Systematic Review Focused on Older Adults

Systematic Review
Written By Simran Padam

Journal of the National Comprehensive Cancer Network

View publication ↗

DOWNLOAD PDF

Simran Padam
Previous

Phase I/II Trial of Palbociclib, Pembrolizumab, and Letrozole in Patients with Hormone Receptor-Positive Metastatic Breast Cancer
Next

Phase II Study of Neratinib in Older Adults with HER2 Amplified or HER2/3 Metastatic Breast Cancer